Massimo Libra

25.4k total citations · 5 hit papers
290 papers, 15.9k citations indexed

About

Massimo Libra is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Massimo Libra has authored 290 papers receiving a total of 15.9k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Molecular Biology, 81 papers in Oncology and 65 papers in Cancer Research. Recurrent topics in Massimo Libra's work include Melanoma and MAPK Pathways (30 papers), PI3K/AKT/mTOR signaling in cancer (28 papers) and MicroRNA in disease regulation (22 papers). Massimo Libra is often cited by papers focused on Melanoma and MAPK Pathways (30 papers), PI3K/AKT/mTOR signaling in cancer (28 papers) and MicroRNA in disease regulation (22 papers). Massimo Libra collaborates with scholars based in Italy, United States and Greece. Massimo Libra's co-authors include Luca Falzone, James A. McCubrey, Linda S. Steelman, Alberto M. Martelli, Saverio Candido, Franca Stivala, Stephen L. Abrams, Jörg Bäsecke, Ferdinando Nicoletti and Demetrios�� Spandidos and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Massimo Libra

284 papers receiving 15.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

2006 1.9k citations James A. McCubrey, Linda S. Steelman et al. profile →
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

2018 622 citations Luca Falzone, Massimo Libra et al. profile →
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

2006 550 citations James A. McCubrey, Linda S. Steelman et al. profile →
Cutaneous melanoma: From pathogenesis to therapy (Review)

2018 428 citations Luca Falzone, Rossella Salemi et al. profile →
Gut Microbiota and Cancer: From Pathogenesis to Therapy

2019 408 citations Silvia Vivarelli, Rossella Salemi et al. profile →

Peers

Countries citing papers authored by Massimo Libra

Since Specialization

Citations

This map shows the geographic impact of Massimo Libra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Libra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Libra more than expected).

Fields of papers citing papers by Massimo Libra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Libra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Libra. The network helps show where Massimo Libra may publish in the future.

Co-authorship network of co-authors of Massimo Libra

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Libra. A scholar is included among the top collaborators of Massimo Libra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Libra. Massimo Libra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 2024 ·Journal of Personalized Medicine ·Alessandro Lavoro, (unknown), Giuseppe Gattuso, (unknown), Luca Falzone, Saverio Candido, Massimo Libra, Mario Salmeri	7
2	Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 2024 ·International Journal of Molecular Medicine ·Giuseppe Gattuso, Alessandro Lavoro, Rosario Caltabiano, Gabriele Madonna, Mariaelena Capone, Paolo A. Ascierto, Luca Falzone, Massimo Libra, Saverio Candido	11
3	Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer 2023 ·Pharmaceutics ·(unknown), Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Călina, Massimo Libra, Luca Falzone	13
4	Ketogenic Diet and Breast Cancer: Recent Findings and Therapeutic Approaches 2023 ·Nutrients ·(unknown), (unknown), Giuseppe Gattuso, (unknown), Gabriella Marsala, Daniela Călina, Massimo Libra, Luca Falzone	20
5	Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 2022 ·Biomolecules ·Rossella Salemi, Giuseppe Gattuso, Barbara Tomasello, Alessandro Lavoro, Agostino Gaudio, Massimo Libra, Salvatore Santo Signorelli, Saverio Candido	12
6	Chronic Pesticide Exposure in Farm Workers Is Associated with the Epigenetic Modulation of hsa-miR-199a-5p 2022 ·International Journal of Environmental Research and Public Health ·Giuseppe Gattuso, Luca Falzone, Chiara Costa, Federica Giambò, Michele Teodoro, Silvia Vivarelli, Massimo Libra, Concettina Fenga	6
7	Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme 2021 ·Pharmaceuticals ·(unknown), Luca Falzone, A Caponnetto, Giuseppe Gattuso, Cristina Barbagallo, Rosalia Battaglia, Federica Mirabella, Giuseppe Broggi, Roberto Altieri, Francesco Certo, Rosario Caltabiano, Giuseppe Barbagallo, Paolo Musumeci, Marco Ragusa, Cinzia Di Pietro, Massimo Libra, Michele Purrello, Davide Barbagallo	83
8	SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19 2020 ·Food and Chemical Toxicology ·Aristides Tsatsakis, Daniela Călina, Luca Falzone, Dimitrios Petrakis, Radu Mitruţ, Vasileios Siokas, Manuela Pennisi, Giuseppe Lanza, Massimo Libra, Sotirios G. Doukas, Panagiotis G. Doukas, (unknown), (unknown), Chiranjeevi Gadiparthi, Dimitra P. Vageli, Diamantis P. Kofteridis, Demetrios�� Spandidos, Mônica Maria Bastos Paoliello, Michael Aschner, Anca Oana Docea	113
9	Association between Nutrient-Based Dietary Patterns and Bladder Cancer in Italy 2020 ·Nutrients ·Valeria Edefonti, Carlo La Vecchia, Matteo Di Maso, Anna Crispo, Jerry Polesel, Massimo Libra, Maria Parpinel, Diego Serraino, Monica Ferraroni, Francesca Bravi	14
10	Cancer therapy and treatments during COVID-19 era 2020 ·Advances in Biological Regulation ·Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Saverio Candido, Massimo Libra, (unknown), Lucio Cocco, Giulia Ramazzotti, Stefano Ratti, Matilde Y. Follo, Alberto M. Martelli, William L. Blalock, Manuela Piazzi, Giuseppe Montalto, Melchiorre Cervello, Monica Notarbartolo, Jörg Bäsecke, James A. McCubrey	33
11	Vinflunina: ancora un’opzione per i pazienti con carcinoma uroteliale avanzato trattati con inibitori dei checkpoint immunitari? 2019 ·Recenti Progressi in Medicina ·Giuseppe Luigi Banna, Francesco Rundo, Helga Lipari, Rosario Di Quattro, (unknown), Massimo Libra, Lorenzo Malatino	1
12	Dietary inflammatory index and cancer risk in the elderly: A pooled-analysis of Italian case-control studies 2019 ·Nutrition ·Giulia Accardi, Nitin Shivappa, Matteo Di Maso, James R. Hébert, Lucia Fratino, Maurizio Montella, Carlo La Vecchia, Calogero Caruso, Diego Serraino, Massimo Libra, Jerry Polesel	27
13	Food consumption, meat cooking methods and diet diversity and the risk of bladder cancer 2019 ·Cancer Epidemiology ·Matteo Di Maso, Federica Turati, Cristina Bosetti, Maurizio Montella, Massimo Libra, Eva Negri, Monica Ferraroni, Carlo La Vecchia, Diego Serraino, Jerry Polesel	17
14	Processed Meat and Risk of Renal Cell and Bladder Cancers 2018 ·Nutrition and Cancer ·Valentina Rosato, Eva Negri, Diego Serraino, Maurizio Montella, Massimo Libra, Παγώνα Λάγιου, Gaetano Facchini, Monica Ferraroni, Adriano Decarli, Carlo La Vecchia	8
15	Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes 2016 ·Journal of Cellular Physiology ·Anna Crispo, Livia S. A. Augustin, Maria Grimaldi, Flavia Nocerino, Aldo Giudice, (unknown), M. Di Bonito, Gerardo Botti, Michelino De Laurentiis, Massimo Rinaldo, Emanuela Esposito, Gabriele Riccardi, Alfonso Amore, Massimo Libra, Gennaro Ciliberto, David J.A. Jenkins, Maurizio Montella	15
16	Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells 2011 ·Cell Cycle ·Linda S. Steelman, Patrick M. Navolanic, William H. Chappell, Stephen L. Abrams, Ellis W.T. Wong, Alberto M. Martelli, Lucio Cocco, Franca Stivala, Massimo Libra, Ferdinando Nicoletti, Л. Б. Дробот, Richard A. Franklin, James A. McCubrey	70
17	The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt 2009 ·Molecular Cancer Therapeutics ·Danijela Maksimović‐Ivanić, Sanja Mijatović, Djordje Miljković, Ljubica Harhaji‐Trajkovic, Gordana Timotijević, Marija Mojić, Darrin Dabideen, Kai Cheng, James A. McCubrey, Katia Mangano, Yousef Al‐Abed, Massimo Libra, Gianni Garotta, Stanislava Stošić‐Grujičić, Ferdinando Nicoletti	37
18	Emerging Raf inhibitors 2009 ·Expert Opinion on Emerging Drugs ·James A. McCubrey, Linda S. Steelman, Steven L. Abrams, William H. Chappell, Suzanne Russo, Roger Ove, Michèle Milella, Agostino Tafuri, Paolo Lunghi, Antonio Bonati, Franca Stivala, Ferdinando Nicoletti, Massimo Libra, Alberto M. Martelli, Giuseppe Montalto, Melchiorre Cervello	26
19	Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 2008 ·Clinical Cancer Research ·Giancarlo Castellano, Grazia Malaponte, María Clorinda Mazzarino, Mariangela Figini, Francesco P. Marchese, Pietro Gangemi, Salvatore Travali, Franca Stivala, Silvana Canevari, Massimo Libra	98
20	Characteristics of rituximab-resistant B-NHL clones: deficiencies in rituximab-mediated changes in lipid raft microdomains and cell signaling 2006 ·Cancer Research ·Ali R. Jazirehi, Christine Bezombes, (unknown), Massimo Libra, Benjamin Bonavida	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact